Human Immunoglobulin G1 (IgG1) Antibody

<strong>Human Immunoglobulin G1 (IgG1) Antibody</strong>_x000D_ <strong>Catalog number:</strong> B2015597_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 150 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> IgG1, ig, immunoglobuling1, immunoglobulin g1, immunoglobulin GI, immnuoglobulin, igg, Ig gamma 1 Chain C Region_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Vattepu R, Sneed SL, Anthony RM. Sialylation as an Important Regulator of Antibody Function Front Immunol. 2022 Apr 7;13:818736._x000D_ 2: Palmeira P, Quinello C, Silveira-Lessa AL, Zago CA, Carneiro-Sampaio M. IgG placental transfer in healthy and pathological pregnancies Clin Dev Immunol. 2012;2012:985646._x000D_ 3: Weber F, Bohrmann B, Niewoehner J, Fischer JAA, Rueger P, Tiefenthaler G, Moelleken J, Bujotzek A, Brady K, Singer T, Ebeling M, Iglesias A, Freskgård PO. Brain Shuttle Antibody for Alzheimer's Disease with Attenuated Peripheral Effector Function due to an Inverted Binding Mode Cell Rep. 2018 Jan 2;22(1):149-162._x000D_ 4: Henderikx P, Coolen-van Neer N, Jacobs A, van der Linden E, Arends JW, Müllberg J, Hoogenboom HR. A human immunoglobulin G1 antibody originating from an in vitro-selected Fab phage antibody binds avidly to tumor-associated MUC1 and is efficiently internalized Am J Pathol. 2002 May;160(5):1597-608._x000D_ 5: Liu H, May K. Disulfide bond structures of IgG molecules: structural variations, chemical modifications and possible impacts to stability and biological function MAbs. 2012 Jan-Feb;4(1):17-23._x000D_ 6: Vietzen H, Görzer I, Puchhammer-Stöckl E. Association of Human Immunoglobulin G1 Heavy Chain Variants With Neutralization Capacity and Antibody-Dependent Cellular Cytotoxicity Against Human Cytomegalovirus J Infect Dis. 2016 Oct 15;214(8):1175-9._x000D_ 7: Markham A. Guselkumab: First Global Approval Drugs. 2017 Sep;77(13):1487-1492._x000D_ 8: Bournazos S, Vo HTM, Duong V, Auerswald H, Ly S, Sakuntabhai A, Dussart P, Cantaert T, Ravetch JV. Antibody fucosylation predicts disease severity in secondary dengue infection Science. 2021 Jun 4;372(6546):1102-1105._x000D_ 9: Zebedee SL, Koduri RK, Mukherjee J, Mukherjee S, Lee S, Sauer DF, Scharff MD, Casadevall A. Mouse-human immunoglobulin G1 chimeric antibodies with activities against Cryptococcus neoformans Antimicrob Agents Chemother. 1994 Jul;38(7):1507-14._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/37063852">10: von Gunten S, Schneider C, Imamovic L, Gorochov G. Antibody diversity in IVIG: Therapeutic opportunities for novel immunotherapeutic drugs Front Immunol. 2023 Mar 28;14:1166821. </a>_x000D_ _x000D_ <strong>Products Related to Human Immunoglobulin G1 (IgG1) Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>